Human Papilloma Virus Clinical Trials

20 recruiting

Human Papilloma Virus Trials at a Glance

28 actively recruiting trials for human papilloma virus are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Montreal, Antwerp, and Atlanta. Lead sponsors running human papilloma virus studies include Universiteit Antwerpen, Emory University, and Centre hospitalier de l'Université de Montréal (CHUM).

Browse human papilloma virus trials by phase

Treatments under study

About Human Papilloma Virus Clinical Trials

Looking for clinical trials for Human Papilloma Virus? There are currently 20 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Human Papilloma Virus trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Human Papilloma Virus clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 28 trials

Recruiting
Phase 2

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

Oropharyngeal CancerThroat CancerHuman Papilloma Virus+2 more
Memorial Sloan Kettering Cancer Center121 enrolled7 locationsNCT05491512
Recruiting
Early Phase 1

Merck IIT: RRP Pembro and Lenvatinib

Pulmonary DiseaseRecurrent Respiratory PapillomatosisHuman Papilloma Virus
Yale University20 enrolled1 locationNCT04645602
Recruiting

Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma

Human Papilloma VirusOropharyngeal Carcinoma
Stanford University1,000 enrolled1 locationNCT05880797
Recruiting

HPV Equity Study: Exploring Cervical Cancer Control in Scotland for Women With Experience of Priority Risks

Human Papilloma Virus
University of Edinburgh500 enrolled1 locationNCT06414057
Recruiting
Phase 2

Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After HPV Vaccination

Human Papilloma Virus Infection Type 16
Universiteit Antwerpen50 enrolled3 locationsNCT07407569
Recruiting
Phase 1Phase 2

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

Head and Neck CancerHPV Positive Oropharyngeal Squamous Cell CarcinomaHuman Papilloma Virus+1 more
University of Chicago98 enrolled1 locationNCT05108870
Recruiting
Not Applicable

The STOP-HPV Scale Up Study

Human Papilloma Virus Vaccine
University of California, Los Angeles100,000 enrolled1 locationNCT06831383
Recruiting

Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

Cervical CancerHuman Papilloma Virus (HPV)
University of Florida55 enrolled1 locationNCT07214584
Recruiting
Phase 4

A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV

Human Papilloma VirusHPVHuman Immunodeficiency Virus
University of British Columbia275 enrolled10 locationsNCT05495906
Recruiting
Phase 3

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)

Human Papilloma Virus (HPV)WartsCommon Warts+1 more
Verrica Pharmaceuticals Inc.300 enrolled6 locationsNCT07246590
Recruiting

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Streptococcus PneumoniaeMalariaMeningitis+55 more
Institut Pasteur du Cambodge10,000 enrolled1 locationNCT07358910
Recruiting
Not Applicable

Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine

Human Papilloma Virus
University of Colorado, Denver1,000 enrolled1 locationNCT04611022
Recruiting

Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling

Human Papilloma Virus
Atila Biosystems Inc.5,000 enrolled4 locationsNCT07232355
Recruiting
Phase 2

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts

Human Papilloma VirusWarts
Zagazig University162 enrolled1 locationNCT05291845
Recruiting
Phase 3

Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer

Head and Neck CancerOropharynx CancerHuman Papilloma Virus
Centre hospitalier de l'Université de Montréal (CHUM)360 enrolled2 locationsNCT04178174
Recruiting
Phase 2

Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV

Human Papilloma VirusAnal DysplasiaHIV
University of Maryland, Baltimore120 enrolled2 locationsNCT06624839
Recruiting
Phase 1

Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery

Oropharyngeal CancerSquamous Cell CarcinomaHuman Papilloma Virus+1 more
Ryan Carey30 enrolled1 locationNCT06747390
Recruiting
Not Applicable

Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study

Human Papilloma VirusHuman Papilloma Virus Vaccine
Emory University365 enrolled4 locationsNCT05065840
Recruiting
Not Applicable

HPV-based Screening Among Women 23-29 Years of Age

Cervical CancerHuman Papilloma VirusCervical Intraepithelial Neoplasia
Karolinska Institutet180,000 enrolled2 locationsNCT05229679
Recruiting

Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia

Human Papilloma VirusCervical DysplasiaVaginal Flora Imbalance+1 more
Hadassah Medical Organization90 enrolled1 locationNCT05640700